IOL CHEMICALS & PHARM. | CIAN HEALTHCARE | IOL CHEMICALS & PHARM./ CIAN HEALTHCARE |
|||
---|---|---|---|---|---|
P/E (TTM) | x | 13.7 | - | - | View Chart |
P/BV | x | 1.6 | 0.9 | 168.5% | View Chart |
Dividend Yield | % | 1.0 | 0.0 | - |
IOL CHEMICALS & PHARM. CIAN HEALTHCARE |
EQUITY SHARE DATA | |||||
---|---|---|---|---|---|
IOL CHEMICALS & PHARM. Mar-23 |
CIAN HEALTHCARE Mar-23 |
IOL CHEMICALS & PHARM./ CIAN HEALTHCARE |
5-Yr Chart Click to enlarge
|
||
High | Rs | 537 | 32 | 1,683.0% | |
Low | Rs | 272 | 12 | 2,268.3% | |
Sales per share (Unadj.) | Rs | 377.6 | 27.4 | 1,376.4% | |
Earnings per share (Unadj.) | Rs | 23.7 | 0.8 | 2,918.7% | |
Cash flow per share (Unadj.) | Rs | 31.6 | 3.0 | 1,057.6% | |
Dividends per share (Unadj.) | Rs | 4.00 | 0 | - | |
Avg Dividend yield | % | 1.0 | 0 | - | |
Book value per share (Unadj.) | Rs | 256.8 | 23.0 | 1,116.8% | |
Shares outstanding (eoy) | m | 58.71 | 25.00 | 234.8% | |
Bonus / Rights / Conversions | 0 | 0 | - | ||
Price / Sales ratio | x | 1.1 | 0.8 | 133.9% | |
Avg P/E ratio | x | 17.1 | 27.0 | 63.1% | |
P/CF ratio (eoy) | x | 12.8 | 7.4 | 174.3% | |
Price / Book Value ratio | x | 1.6 | 1.0 | 165.0% | |
Dividend payout | % | 16.9 | 0 | - | |
Avg Mkt Cap | Rs m | 23,743 | 549 | 4,328.5% | |
No. of employees | `000 | NA | NA | - | |
Total wages/salary | Rs m | 1,682 | 89 | 1,898.1% | |
Avg. sales/employee | Rs Th | 0 | 0 | - | |
Avg. wages/employee | Rs Th | 0 | 0 | - | |
Avg. net profit/employee | Rs Th | 0 | 0 | - |
INCOME DATA | |||||
---|---|---|---|---|---|
Net Sales | Rs m | 22,171 | 686 | 3,232.4% | |
Other income | Rs m | 256 | 6 | 4,144.0% | |
Total revenues | Rs m | 22,427 | 692 | 3,240.6% | |
Gross profit | Rs m | 2,257 | 131 | 1,722.4% | |
Depreciation | Rs m | 462 | 54 | 849.9% | |
Interest | Rs m | 165 | 63 | 261.5% | |
Profit before tax | Rs m | 1,887 | 20 | 9,475.1% | |
Minority Interest | Rs m | 0 | 0 | - | |
Prior Period Items | Rs m | 0 | 0 | - | |
Extraordinary Inc (Exp) | Rs m | 0 | 0 | - | |
Tax | Rs m | 495 | 0 | -126,948.7% | |
Profit after tax | Rs m | 1,391 | 20 | 6,854.2% | |
Gross profit margin | % | 10.2 | 19.1 | 53.3% | |
Effective tax rate | % | 26.2 | -1.9 | -1,350.2% | |
Net profit margin | % | 6.3 | 3.0 | 212.1% |
BALANCE SHEET DATA | |||||
---|---|---|---|---|---|
Current assets | Rs m | 9,667 | 742 | 1,302.0% | |
Current liabilities | Rs m | 5,025 | 653 | 770.0% | |
Net working cap to sales | % | 20.9 | 13.1 | 159.9% | |
Current ratio | x | 1.9 | 1.1 | 169.1% | |
Inventory Days | Days | 43 | 94 | 45.9% | |
Debtors Days | Days | 8 | 1,396 | 0.6% | |
Net fixed assets | Rs m | 11,017 | 762 | 1,446.2% | |
Share capital | Rs m | 587 | 250 | 234.9% | |
"Free" reserves | Rs m | 14,490 | 325 | 4,459.7% | |
Net worth | Rs m | 15,077 | 575 | 2,622.8% | |
Long term debt | Rs m | 0 | 294 | 0.0% | |
Total assets | Rs m | 20,684 | 1,605 | 1,288.9% | |
Interest coverage | x | 12.5 | 1.3 | 946.3% | |
Debt to equity ratio | x | 0 | 0.5 | 0.0% | |
Sales to assets ratio | x | 1.1 | 0.4 | 250.8% | |
Return on assets | % | 7.5 | 5.2 | 145.0% | |
Return on equity | % | 9.2 | 3.5 | 261.4% | |
Return on capital | % | 13.6 | 9.5 | 142.6% | |
Exports to sales | % | 26.7 | 13.7 | 194.9% | |
Imports to sales | % | 0 | 0 | - | |
Exports (fob) | Rs m | 5,930 | 94 | 6,299.9% | |
Imports (cif) | Rs m | NA | NA | - | |
Fx inflow | Rs m | 5,930 | 94 | 6,299.9% | |
Fx outflow | Rs m | 6,052 | 0 | 7,564,750.0% | |
Net fx | Rs m | -122 | 94 | -129.4% |
CASH FLOW | |||||
---|---|---|---|---|---|
From Operations | Rs m | 1,223 | 48 | 2,525.7% | |
From Investments | Rs m | -1,200 | 26 | -4,696.7% | |
From Financial Activity | Rs m | -41 | -74 | 55.5% | |
Net Cashflow | Rs m | -18 | 0 | 15,333.3% |
Indian Promoters | % | 48.2 | 27.1 | 177.8% | |
Foreign collaborators | % | 0.0 | 0.0 | - | |
Indian inst/Mut Fund | % | 1.7 | 0.0 | - | |
FIIs | % | 1.4 | 0.0 | - | |
ADR/GDR | % | 0.0 | 0.0 | - | |
Free float | % | 51.8 | 72.9 | 71.1% | |
Shareholders | 130,003 | 880 | 14,773.1% | ||
Pledged promoter(s) holding | % | 0.0 | 47.8 | - |
Compare IOL CHEMICALS & PHARM. With: DIVIS LABORATORIES CIPLA SUN PHARMA ZYDUS LIFESCIENCES DR. REDDYS LAB
No comparison is complete without understanding how the stock prices have performed over a period of time.
Here's a brief comparison:
Period | IOL CHEMICALS & PHARM. | CIAN HEALTHCARE | S&P BSE HEALTHCARE |
---|---|---|---|
1-Day | 0.11% | 1.10% | 0.45% |
1-Month | 5.76% | 2.66% | 2.55% |
1-Year | -2.63% | -36.34% | 56.14% |
3-Year CAGR | -12.88% | 8.03% | 15.22% |
5-Year CAGR | 16.82% | -19.16% | 19.63% |
* Compound Annual Growth Rate
Here are more details on the IOL CHEMICALS & PHARM. share price and the CIAN HEALTHCARE share price.
Moving on to shareholding structures...
The promoters of IOL CHEMICALS & PHARM. hold a 48.2% stake in the company. In case of CIAN HEALTHCARE the stake stands at 27.1%.
To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of IOL CHEMICALS & PHARM. and the shareholding pattern of CIAN HEALTHCARE.
Finally, a word on dividends...
In the most recent financial year, IOL CHEMICALS & PHARM. paid a dividend of Rs 4.0 per share. This amounted to a Dividend Payout ratio of 16.9%.
CIAN HEALTHCARE paid Rs 0.0, and its dividend payout ratio stood at 0.0%.
You may visit here to review the dividend history of IOL CHEMICALS & PHARM., and the dividend history of CIAN HEALTHCARE.
For a sector overview, read our pharmaceuticals sector report.
After opening the day on high, Indian share markets reversed the trend as the session progressed and ended the lower.